✦ LIBER ✦

Novel molecular approaches toward therapy of chronic hepatitis B

✍ Scribed by M. Nassal

Publisher: Springer Vienna
Year: 1997
Tongue: English
Weight: 502 KB
Volume: 142
Category: Article
ISSN: 1432-8798
DOI: 10.1007/s007050050107

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endpoints of therapy in chronic hepatiti

Endpoints of therapy in chronic hepatitis B

✍ Jordan J. Feld; David K. H. Wong; E. Jenny Heathcote 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Because clearance of hepatitis B virus (HBV) infection is rarely, if ever, achievable, the goals of therapy necessarily focus on prevention of bad clinical outcomes. Ideally, therapies would be shown to prevent tangible clinical endpoints like development of cirrhosis, end-stage liver disease and he

Immune therapy of hepatitis B virus chro

Immune therapy of hepatitis B virus chronic infection

✍ Stanislas Pol; Marie-Louise Michel; Christian Bréchot 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 2 views

Molecular epidemiology of chronic hepati

Molecular epidemiology of chronic hepatitis B virus infection in Greece

✍ Fylaktou Asimina; Papaventsis Dimitrios; Daoudaki Maria; Moskophidis Mathaios; T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB

## Abstract Virological data on chronic hepatitis B virus (HBV) infection in Greece are limited. HBV genotypes, surface antigen (HBsAg) subtypes, and HBsAg “a” determinant mutations among patients infected chronically with HBV, were investigated. Serum samples from 135 HBsAg positive patients were

Reduction of liver stiffness by antivira

Reduction of liver stiffness by antiviral therapy in chronic hepatitis B

✍ Keisuke Osakabe; Naohiro Ichino; Toru Nishikawa; Hiroko Sugiyama; Miho Kato; Shi 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 356 KB

The molecular and pathophysiological imp

The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection

✍ Samuel Martin-Vilchez; Enrique Lara-Pezzi; Maria Trapero-Marugán; Ricardo Moreno 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

## SUMMARY Hepatitis B virus is considered one of the most significant environmental carcinogens in humans. Because the mechanisms of HBV replication and the development of hepatocellular carcinoma (HCC) are partially known, HBV‐associated pathogenesis remains a challenge to increase its understand

Therapy of chronic hepatitis b with reco

Therapy of chronic hepatitis b with recombinant human alpha and gamma interferon

✍ Adrian M. Di Bisceglie; Vinod K. Rustgi; Chris Kassianides; Mauricio Lisker-Melm 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Eight patients with chronic hepatitis B entered a pilot study of gamma interferon and alpha interferon in combination. Gamma interferon alone had minimal inhibitory effects on serum levels of hepatitis B virus as monitored by serum HBV DNA and DNA-polymerase activity. The drug also gave troublesome